Producing Supreme Cannabis At Scale
Ryan Allway
January 22nd, 2019
Exclusive, News
Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of recreational cannabis last year. While many licensed producers are ramping up capacity, investors may want to shift their focus to the handful of companies that are doubling down on product quality. These companies could evolve into tomorrow’s leading recreational and medical brands.
The Supreme Cannabis Co. (TSX: FIRE) is a licensed producer with an obsession with quality. Through its 7ACRES subsidiary, the company operates one of the most successful premium cannabis brands in the market with over 300,000 sq. ft. of grow space and rapidly growing revenue. Investors may want to take a closer look at the stock as it scales up in 2019 and beyond.
Premium Producer
Many licensed producers are focused on ramping up production amid the chronic supply shortage following recreational legalization last year. Canopy Growth Corp. (NYSE: CGC) (TSX: WEED) and other multi-billion dollar companies may be leading the way in gross square footage and kilograms per year, but some companies have been focusing on differentiating themselves in the crowded market with premium products.
Aurora Cannabis Inc.’s (TSX: ACB) (NYSE: ACB) move to acquire Whistler Medical Marijuana Corporation for $175 million in stock underscores the trend toward quality. As one of the first ten licensed producers in the market, Whistler has developed one of the most recognizable regional cannabis brands, built on quality, award-winning organic certified bud. The company’s products regularly sell for 50 percent more than average in medical and recreational markets.
Supreme Cannabis is similarly focused on high-quality, premium cannabis products. Last year, the company’s 7ACRES brand was named Brand of the Year at the 2018 Canadian Cannabis Awards, while provincial supply agreements regularly list its products in the highest brand category available to recreational consumers. The company’s 440,000 sq. ft. facility in Ontario makes it one of the only premium providers operating at scale in the market.
Gaining Notoriety
Supreme Cannabis has made significant progress in growing shareholder value. In its first year, the company was one of the best revenue performers among any licensed producer and it generated the eighth highest revenue among licensed producers last quarter. The launch of Khalifa Kush products, Medigrow export channels, and other initiatives in 2019 should continue this growth and put the company on investors’ radar.
At the same time, the company recently announced conditional approval to uplist from the TSX Venture exchange to the Toronto Stock Exchange (TSX). To put the move in perspective for U.S. investors, the uplisting is similar to a move from the OTC Markets to the NYSE or NASDAQ, where there is significantly more investor interest and liquidity. This liquidity could help close any valuation discount that exists between the company and industry.
“Graduating to the TSX will broaden our investment appeal and leave us well positioned to execute on our strategic imperatives for 2019, which is why we’re pleased to add this milestone to our list of accomplishments for the year,” said Supreme Cannabis CEO Navdeep Dhaliwal. “Looking forward, we are eager to build on these accomplishments and make significant advancements by cementing 7ACRES as a leading premium flower brand.”
Looking Ahead
The Supreme Cannabis Co. (TSX: FIRE) represents a compelling opportunity in the nascent cannabis industry. With its focus on quality, the company’s 7ACRES brand has set itself apart from the competition. At the same time, the company has managed to scale its premium flower business while maintaining its high margins and premium brand reputation. Investors may want to keep an eye on the stock moving into the new year.
For more information, visit the company’s website at www.supreme.ca.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and/or safety profiles for the treatment of rare diseases and other diseases with high unmet medical needs.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
